Accelus
PrivateLast Round
Early Funding
May 29, 2025
Total Funding Raised
$38.81M
Company Overview
Accelus operates in Healthcare & Life Sciences and is based in Palm Beach Gardens, Florida. Its latest recorded funding round was an Early Funding round in May 2025.
Accelus is a medical technology company that provides a portfolio of MIS spinal implants and a compact precision robotics platform to accelerate the adoption of minimally invasive surgery as the standard of care in spine.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Accelus Comparables
Compare Accelus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amplify Surgical, Inc. | 88% | |
| Spineology | 87% | |
| Spine Wave | 85% |
For institutional investors. Book with your work email.
Accelus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 29, 2025 | ||||
| Debt | Jan 18, 2024 | ||||
| Series D | Jul 12, 2022 | ||||
| Seed | Feb 27, 2020 | ||||
| Angel | Jun 25, 2019 |
For institutional investors. Book with your work email.
Accelus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Symbiotic Capital | Debt |
| Concord Health Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2025
Highridge Medical acquired products and assets to expand spine surgery capabilities.
- May 29, 2025
$6M raised in early funding.
For institutional investors. Book with your work email.
Accelus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Accelus's valuation, stock price, and market status.
Is Accelus a public or private company?
Accelus is a private company.
What is the current stock price of Accelus?
Accelus is a private company, so its shares have no public market price. Caplight tracks Accelus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Accelus worth (valuation)?
Valuation information for Accelus is not publicly available.
Can I buy Accelus stock?
Accelus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Accelus's last funding round?
Accelus's most recent funding round was Early Funding on May 29, 2025.
Who are the main investors in Accelus?
Key investors in Accelus include Symbiotic Capital, Concord Health Partners.
Will Accelus IPO soon?
No public IPO plans have been announced for Accelus.
How can I track Accelus secondary market activity?
Caplight tracks bids, offers, and trades in Accelus's shares on secondary markets.